Cancer stem cells and fibroblast niche cross talk in an in‐vitro oral dysplasia model-Reference-Cited by-同舟云学术

Cancer stem cells and fibroblast niche cross talk in an in‐vitro oral dysplasia model

Published:2019-01-31 Issue:5 Volume:58 Page:820-831
ISSN:0899-1987
Container-title:Molecular Carcinogenesis
language:en
Short-container-title:Mol Carcinog

Author:

Kulsum Safeena¹²,Raju Nalini³,Raghavan Nisheena³,Ramanjanappa Ravindra D. R.¹,Sharma Anupam⁴,Mehta Alka²,Kuriakose Moni A.¹⁵^ORCID,Suresh Amritha¹⁵^ORCID

Affiliation:

1. Integrated Head and Neck Oncology Research ProgramMazumdar Shaw Centre for Translational Research, MSMFBangaloreIndia

2. Department of Integrative BiologySchool of Biosciences and TechnologyVellore Institute of TechnologyVelloreTamil NaduIndia

3. Department of HistopathologyMazumdar Shaw Medical CentreNarayana HealthBangaloreIndia

4. GROW LaboratoryStem Cell Research Lab, Narayana NethralayaNarayana HealthBangaloreIndia

5. Head and Neck OncologyMazumdar Shaw Medical CentreNarayana HrudayalayaBangaloreIndia

Funder

Ministry of Science and Technology

Science and Engineering Research Board

Publisher

Wiley

Subject

Cancer Research,Molecular Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mc.22974

Reference50 articles.

1. Oral verrucous hyperplasia: histologic classification, prognosis, and clinical implications

2. Disease mechanism and biomarkers of oral squamous cell carcinoma

3. Leukoplakia revisited.A clinicopathologic study 3256 oral leukoplakias

4. Should severe epithelial dysplasia be treated?

5. Expression of cell cycle control proteins in normal epithelium, premalignant and malignant lesions of oral cavity

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision Oncology, Signaling Pathways Reprogramming and Targeted Therapy: A Holistic Approach to Molecular Cancer Therapeutics;2024-07-07

2. New insights into the role of the oral leukoplakia microenvironment in malignant transformation;Frontiers in Oral Health;2024-02-21

3. The Precision Oncology Approach to Molecular Cancer Therapeutics Targeting Oncogenic Signaling Pathways is a Means to an End;SSRN Electronic Journal;2024

4. The Precision Oncology Approach to Molecular Cancer Therapeutics Targeting Oncogenic Signaling Pathways is a Means to an End;2023-12-15

5. Targeting Cancer Cell Signaling Using Precision Oncology Towards a Holistic Approach to Cancer Therapeutics;2023-12-04